12-WEEKS OF CHEMOTHERAPY AND INVOLVED FIELD RADIOTHERAPY (RT) ARE HIGHLY EFFECTIVE FOR UNFAVORABLE HODGKINS-DISEASE (HD) - THE STANFORD V REGIMEN

被引：0
|
作者：
BARLETT, NL [1 ]
ROSENBERG, SA [1 ]
HOPPE, RT [1 ]
HORNING, SJ [1 ]
机构：
[1] STANFORD UNIV,MED CTR,STANFORD,CA 94305
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A333 / A333
页数：1
相关论文
共 26 条
  • [1] 12 weeks of chemotherapy (stanford V) and involved field radiotherapy (RT) are highly effective for bulky and advanced stage Hodgkin's disease (HD): A limited institution ecog pilot study.
    Horning, SJ
    Bennett, JM
    Bartlett, NL
    Williams, J
    Neuberg, D
    Cassileth, PA
    BLOOD, 1996, 88 (10) : 2681 - 2681
  • [2] CLINICAL STAGING, PRIMARY CHEMOTHERAPY AND INVOLVED FIELD RADIOTHERAPY IN CHILDHOOD HODGKINS-DISEASE
    OBERLIN, O
    BOILLETOT, A
    LEVERGER, G
    SARRAZIN, D
    SCHAISON, G
    LEMERLE, J
    EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY, 1985, 2 (02): : 65 - 70
  • [3] 12 WEEKS ALTERNATING CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE (HD) RESULTS OF A PILOT-STUDY
    SWEETENHAM, JW
    MEAD, GM
    JEFFERY, GM
    WHITEHOUSE, JMA
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 821 - 821
  • [4] DELAYED CARDIAC DISEASE IN PATIENTS (PTS) TREATED BY THORACIC MANTLE FIELD RADIOTHERAPY (RT) FOR HODGKINS-DISEASE (HD)
    APPLEFELD, MM
    SLAWSON, RG
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1982, 66 (04): : 1063 - 1063
  • [5] ABVD + LIMITED-FIELD LOW-DOSE RADIOTHERAPY (RT) FOR CHILDHOOD HODGKINS-DISEASE (HD)
    FOSSATIBELLANI, F
    GASPARINI, M
    KENDA, R
    LOMBARDI, F
    PIZZETTI, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 234 - 234
  • [6] ABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN PEDIATRIC HODGKINS-DISEASE - THE STANFORD EXPERIENCE
    HUNGER, SP
    LINK, MP
    DONALDSON, SS
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2160 - 2166
  • [7] RADIOTHERAPY (RT) PLUS CHEMOTHERAPY (CT) VERSUS RT ALONE IN EARLY STAGE HODGKINS-DISEASE (HD), A REPORT FROM A RANDOMIZED, NATIONAL DANISH TRIAL
    NISSEN, NI
    NORDENTOFT, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 286 - 286
  • [8] BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
    BARTLETT, NL
    ROSENBERG, SA
    HOPPE, RT
    HANCOCK, SL
    HORNING, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1080 - 1088
  • [9] Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience.
    Advani, R
    Maeda, L
    Hoppe, RT
    Breslin, S
    Rosenberg, SA
    Baer, D
    Mason, J
    Horning, SJ
    BLOOD, 2005, 106 (11) : 548A - 548A
  • [10] EFFICACY AND TOXICITY OF MULTIAGENT CHEMOTHERAPY AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY IN CHILDREN AND ADOLESCENTS WITH HODGKINS-DISEASE
    HUDSON, MM
    GREENWALD, C
    THOMPSON, E
    WILIMAS, J
    MARINA, N
    FAIRCLOUGH, D
    KAUFFMAN, W
    BOZEMAN, P
    MACKERT, PW
    ABROMOWITCH, M
    JENKINS, J
    BOULDEN, T
    KUN, L
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) : 100 - 108
123